Medicare GLP-1 Bridge: New 50 Dollar Monthly Copay for Weight Loss Meds Starts July 1st

In a historic shift for federal health policy, the Centers for Medicare and Medicaid Services (CMS) has announced a new pilot program that will make high-demand weight loss medications affordable for millions of seniors. Starting July 1, 2026, eligible Medicare beneficiaries will be able to access certain GLP-1 medications for a flat $50 monthly copay.

The short-term initiative, titled the Medicare GLP-1 Bridge, is scheduled to run through December 31, 2027. It serves as a transition to a more permanent model expected to launch in 2028.

Breaking the "Weight Loss Gap"

For decades, Medicare has been statutorily prohibited from covering medications used specifically for weight loss. This left many seniors paying upwards of $1,300 a month out-of-pocket for revolutionary drugs like Wegovy and Zepbound.

CMS Administrator Dr. Mehmet Oz stated that the new program is part of the administration's "Most Favored Nation" drug pricing strategy. By negotiating directly with manufacturers like Novo Nordisk and Eli Lilly, the government has secured a net price that allows for the drastically reduced $50 copay.

Who Qualifies for the $50 Copay?

The program is available to seniors enrolled in Medicare Part D (stand-alone or through Medicare Advantage) who meet specific clinical criteria:

• Automatic Qualification: Any beneficiary with a Body Mass Index (BMI) of 35 or higher.

• Conditional Qualification: Beneficiaries with a BMI of 30 or higher if they also have a diagnosis of heart failure, uncontrolled hypertension, or chronic kidney disease.

• Overweight Qualification: Beneficiaries with a BMI of 27 or higher if they have pre-diabetes or a history of cardiovascular issues.

Covered Medications

The "Bridge" program specifically covers FDA-approved formulations for weight management, including:

• Wegovy® (both the weekly injection and the once-daily pill).

• Zepbound® (KwikPen formulation).

• Foundayo® (the new once-daily weight loss pill).

A New Way to File Claims

Seniors should note that this program works differently than standard Part D benefits. To keep costs low and predictable, the Medicare GLP-1 Bridge operates outside the standard insurance risk pool using a central processor.

Doctors will submit prior authorization requests and prescriptions directly to a CMS-contracted system rather than the patient’s private insurance carrier. Notably, because the program is a "demonstration," the $50 copays will not count toward the standard $2,100 Part D out-of-pocket cap or annual deductibles.

"Making these popular drugs more affordable will help seniors live healthier lives," a CMS spokesperson said. "By tackling obesity head-on, we are preventing the downstream costs of diabetes and heart disease."

Explore NBCPalmSprings.com, where we are connecting the valley.